+919405117673
Trabectedin Powder for Injection 1mg – High Quality Oncology API Exporter from India  Cordium Pharma
Trabectedin Powder for Injection 1mg is a potent anti-cancer medication used in modern oncology treatment protocols for specific types of cancers. Manufactured and supplied by Cordium Pharmaceuticals Pvt Ltd, India, we are a trusted global exporter ensuring high-quality pharmaceutical standards, regulatory compliance, and reliable international supply chain support.

πŸ”¬ Medical Usage of Trabectedin

Trabectedin is primarily used in oncology for the treatment of:

Advanced soft tissue sarcoma
Ovarian cancer (relapsed or platinum-sensitive cases)
Other malignant conditions as per oncologist recommendation

It works by interfering with the DNA repair process in cancer cells, helping to slow or stop tumor growth.

πŸ’‰ Dosage Information
The dosage of Trabectedin Powder for Injection 1mg is strictly determined by a qualified oncologist.
It is administered intravenously under medical supervision in a hospital setting.
Dose adjustment may be required based on liver function, body surface area, and patient response.

⚠️ Self-administration is strictly prohibited.

⚠️ Side Effects

Common and clinically observed side effects may include:

Nausea and vomiting
Fatigue and weakness
Decreased white blood cell count (neutropenia)
Liver enzyme elevation
Loss of appetite
Injection site reactions

Serious adverse effects require immediate medical attention.

🌍 Global Export & Fast Delivery

Cordium Pharmaceuticals Pvt Ltd is a reliable exporter of oncology medicines with fast and secure international supply to:

πŸ‡ΊπŸ‡Έ United States | πŸ‡©πŸ‡ͺ Germany | πŸ‡¬πŸ‡§ United Kingdom | πŸ‡³πŸ‡± Netherlands | πŸ‡ΏπŸ‡¦ South Africa | πŸ‡¦πŸ‡ͺ United Arab Emirates | πŸ‡§πŸ‡· Brazil

We ensure:

WHO-GMP certified quality standards
Secure pharmaceutical packaging
Timely global shipping support
Regulatory documentation assistance
πŸ“ž Contact for Business Inquiry

πŸ“± WhatsApp: +91-9405117673
πŸ“§ Email: info@cordiumpharma.com
Apr 18th, 2026 11:56 AM

Keywords